Related Experiment Video

Updated: Jul 24, 2026

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children
04:55

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children

Published on: September 11, 2018

Clinician follow-up of children screened for lead poisoning

M Markowitz1, J F Rosen, I Clemente

  • 1Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY 10467, USA.

American Journal of Public Health
|July 8, 1999
PubMed

Insights

Clinician follow-up for children with elevated blood lead (BPb) levels is inadequate. Many children with high BPb require timely retesting to prevent long-term health issues.

Area of Science:

  • Pediatric Environmental Health
  • Public Health Surveillance
  • Clinical Compliance

Background:

  • Elevated blood lead (BPb) levels in children pose significant health risks.
  • The Centers for Disease Control and Prevention (CDC) provide guidelines for managing childhood lead exposure.
  • Effective follow-up care is crucial for mitigating lead toxicity.

Purpose of the Study:

  • To evaluate clinician adherence to CDC guidelines for managing children with elevated blood lead levels (BPb).
  • To assess the adequacy of follow-up care for pediatric patients with varying BPb concentrations.

Main Methods:

  • Retrospective analysis of 410 children with BPb levels ≥ 0.48 mumol/L (10 µg/dL) over 12 months.
  • Categorization of children into three BPb ranges: ≥ 0.97 mumol/L, 0.73–0.92 mumol/L, and 0.48–0.68 mumol/L.
  • Determination of retesting rates within 4 months for each BPb category.

Main Results:

  • Within 4 months, 71% of children with initial BPb ≥ 0.97 mumol/L were retested.
  • Retesting rates were lower for children with lower BPb levels: 57% for 0.73–0.92 mumol/L and 34% for 0.48–0.68 mumol/L.
  • Overall follow-up compliance fell short of recommended standards.

Conclusions:

  • Follow-up care for children with elevated blood lead levels is insufficient within this urban ambulatory care network.
  • There is a critical need to improve adherence to lead exposure management protocols.
  • Enhanced strategies are required to ensure timely and appropriate care for children with lead poisoning.
Abstract

More Related Videos

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...